Product NDC: | 0173-0880 |
Proprietary Name: | TABLOID |
Non Proprietary Name: | thioguanine |
Active Ingredient(s): | 40 mg/1 & nbsp; thioguanine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0880 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA012429 |
Marketing Category: | NDA |
Start Marketing Date: | 19841218 |
Package NDC: | 0173-0880-25 |
Package Description: | 25 TABLET in 1 BOTTLE (0173-0880-25) |
NDC Code | 0173-0880-25 |
Proprietary Name | TABLOID |
Package Description | 25 TABLET in 1 BOTTLE (0173-0880-25) |
Product NDC | 0173-0880 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | thioguanine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19841218 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | THIOGUANINE |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antimetabolite [EPC] |